A new era of advanced manufacturing technology is taking over the pharmaceutical sector, with the goals of enhancing product quality, streamlining processes, and confirming regulatory compliance. “Process Analytical Technology (PAT)” has appeared as a key framework for monitoring and controlling pharmaceutical manufacturing processes in real time. The addition of “Artificial Intelligence (AI)” and “Machine Learning (ML)” with PAT has significantly enhanced predictive modeling, data interpretation, and process optimization in modern pharmaceutical production systems. AI-enabled PAT systems facilitate “Real-Time Release Testing (RTRT)”, enabling quality assessment during manufacturing rather than depend on traditional end-product testing. Continuous pharmaceutical manufacturing further benefits from AI-driven analytics by enabling dynamic process control, improved efficiency, and reduced manufacturing variability. This review discusses the fundamental concepts of PAT, the application of AI in pharmaceutical manufacturing, and the role of AI-enabled PAT systems in enabling real-time release testing and continuous production. The review also highlights regulatory perspectives, technological challenges, and future opportunities for implementing AI-integrated analytical frameworks in pharmaceutical quality assurance. The adoption of AI-driven PAT platforms is expected to transform pharmaceutical manufacturing toward fully automated, data-driven, and intelligent production environments that ensure consistent product quality and operational efficiency.